Reappraising the role of inflammation in heart failure

L Adamo, C Rocha-Resende, SD Prabhu… - Nature Reviews …, 2020 - nature.com
The observation that heart failure with reduced ejection fraction is associated with elevated
circulating levels of pro-inflammatory cytokines opened a new area of research that has …

Inflammatory cytokines and chemokines as therapeutic targets in heart failure

A Hanna, NG Frangogiannis - Cardiovascular Drugs and Therapy, 2020 - Springer
Heart failure exhibits remarkable pathophysiologic heterogeneity. A large body of evidence
suggests that regardless of the underlying etiology, heart failure is associated with induction …

Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure

BM Everett, JH Cornel, M Lainscak, SD Anker… - Circulation, 2019 - Am Heart Assoc
Background: Subclinical inflammation is associated with an increased risk of heart failure
and with adverse prognosis in patients with established heart failure. Yet, treatments …

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe …

ES Chung, M Packer, KH Lo, AA Fasanmade… - Circulation, 2003 - Am Heart Assoc
Background–Preclinical and preliminary clinical data have suggested that tumor necrosis
factor-α (TNFα) may play a role in the evolution and progression of heart failure and that …

[HTML][HTML] Current and future therapeutic perspective in chronic heart failure

A Mascolo, G Di Mauro, D Cappetta… - Pharmacological …, 2022 - Elsevier
The incidence of heart failure is primarily flat or declining for a presumably reflecting better
management of cardiovascular diseases, but that of heart failure with preserved ejection …

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

DL Mann - Circulation research, 2002 - Am Heart Assoc
Recent studies have identified the importance of proinflammatory mediators in the
development and progression of heart failure. The growing appreciation of the …

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

A Kumar, V Thota, L Dee, J Olson, E Uretz… - The Journal of …, 1996 - rupress.org
Previous studies have demonstrated the presence of myocardial depression in clinical and
experimental septic shock. This depression is associated with the presence of a circulating …

Mechanisms of sepsis-induced cardiac dysfunction

A Rudiger, M Singer - Critical care medicine, 2007 - journals.lww.com
Objectives: To review mechanisms underlying sepsis-induced cardiac dysfunction in
general and intrinsic myocardial depression in particular. Data Source: MEDLINE database …

Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart

G Torre-Amione, S Kapadia, J Lee, JB Durand… - Circulation, 1996 - Am Heart Assoc
Background Tumor necrosis factor-α (TNF-α) is a proinflammatory cytokine that produces
negative inotropic effects in the heart. Recently, elevated levels of TNF-α have been …

Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats

B Bozkurt, SB Kribbs, FJ Clubb Jr, LH Michael… - Circulation, 1998 - Am Heart Assoc
Background—Although patients with heart failure express elevated circulating levels of
tumor necrosis factor-α (TNF-α) in their peripheral circulation, the structural and functional …